Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 109.06 USD -2.96%
Market Cap: 135.8B USD

Intrinsic Value

The intrinsic value of one GILD stock under the Base Case scenario is 101.51 USD. Compared to the current market price of 109.06 USD, Gilead Sciences Inc is Overvalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GILD Intrinsic Value
101.51 USD
Overvaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Gilead Sciences Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
GILD
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GILD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Gilead Sciences Inc
NASDAQ:GILD
US
Biotechnology
Market Cap
135.9B USD
IPO
Jan 22, 1992
US
Biotechnology
Market Cap
135.9B USD
IPO
Jan 22, 1992
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Gilead’s heavy reliance on its HIV portfolio could hinder long-term growth if new competitive therapies and emerging generics erode market share faster than forecast, putting pressure on revenues and margins.

Bull Theses

Gilead’s robust HIV franchise, led by Biktarvy, continues to post solid growth and enjoy strong patent protection, providing a stable revenue base and healthy cash flow to fund R&D and strategic acquisitions.

Show More Less
How do you feel about GILD?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Gilead Sciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Gilead Sciences Inc

Current Assets 19.2B
Cash & Short-Term Investments 10B
Receivables 4.4B
Other Current Assets 4.8B
Non-Current Assets 39.8B
PP&E 5.4B
Intangibles 28.3B
Other Non-Current Assets 6.1B
Efficiency

Free Cash Flow Analysis
Gilead Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Gilead Sciences Inc

Revenue
28.8B USD
Cost of Revenue
-6.3B USD
Gross Profit
22.5B USD
Operating Expenses
-11.7B USD
Operating Income
10.8B USD
Other Expenses
-10.3B USD
Net Income
480m USD
Fundamental Scores

GILD Profitability Score
Profitability Due Diligence

Gilead Sciences Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive Operating Income
Positive 3-Year Average ROE
62/100
Profitability
Score

Gilead Sciences Inc's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

GILD Solvency Score
Solvency Due Diligence

Gilead Sciences Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
High Interest Coverage
53/100
Solvency
Score

Gilead Sciences Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GILD Price Targets Summary
Gilead Sciences Inc

Wall Street analysts forecast GILD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GILD is 112.8 USD with a low forecast of 82.82 USD and a high forecast of 147 USD.

Lowest
Price Target
82.82 USD
24% Downside
Average
Price Target
112.8 USD
3% Upside
Highest
Price Target
147 USD
35% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GILD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GILD Insider Trading
Buy and sell transactions by insiders

GILD News

Other Videos
What is the Intrinsic Value of one GILD stock?

The intrinsic value of one GILD stock under the Base Case scenario is 101.51 USD.

Is GILD stock undervalued or overvalued?

Compared to the current market price of 109.06 USD, Gilead Sciences Inc is Overvalued by 7%.

Back to Top